MedTrace Logo

Reduction of Cesareans by Nitric Oxide (NO) Donors in Post Term Pregnancies

NCT00930618 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1409

Last updated 2025-12-01

No results posted yet for this study

Summary

The purpose of this trial is to determine whether cervical ripening with isosorbide mononitrate reduce caesarean section in women with post term pregnancies.

Conditions

  • Prolonged Pregnancy
  • Nulliparity

Interventions

DRUG

IMN

Administration of 2 x 20 mg of isosorbide mononitrate at each administration with a maximum of three administrations

DRUG

Placebo

Administration of 2 X 20 mg of placebo of IMN at each administration with a maximum of three administration

Sponsors & Collaborators

  • URC-CIC Paris Descartes Necker Cochin

    collaborator OTHER

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • François Goffinet, MD, PhD · Scientific Responsible

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2013-12-31
Completion
2014-04-30

Countries

  • France

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00930618 on ClinicalTrials.gov